Altamira Therapeutics Ltd. (CYTO)
NASDAQ: CYTO · IEX Real-Time Price · USD
1.170
-0.010 (-0.85%)
At close: Jul 26, 2024, 3:52 PM
1.150
-0.020 (-1.71%)
After-hours: Jul 26, 2024, 6:08 PM EDT
Altamira Therapeutics Market Cap
Altamira Therapeutics has a market cap or net worth of $2.62 million as of July 26, 2024. Its market cap has decreased by -12.63% in one year.
Market Cap
2.62M
Enterprise Value
2.04M
1-Year Change
-12.63%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since December 31, 2014, Altamira Therapeutics's market cap has decreased from $113.10M to $2.62M, a decrease of -97.68%. That is a compound annual growth rate of -32.52%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 25, 2024 | 1.70M | 21.43% |
Dec 29, 2023 | 1.40M | -65.85% |
Dec 30, 2022 | 4.10M | -83.47% |
Dec 31, 2021 | 24.80M | 86.47% |
Dec 31, 2020 | 13.30M | 343.33% |
Dec 31, 2019 | 3.00M | 36.36% |
Dec 31, 2018 | 2.20M | -89.16% |
Dec 29, 2017 | 20.30M | -44.69% |
Dec 30, 2016 | 36.70M | -74.15% |
Dec 31, 2015 | 142.00M | 25.55% |
Dec 31, 2014 | 113.10M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Virax Biolabs Group | 2.76M |
INVO Bioscience | 2.75M |
Aditxt | 2.75M |
Avenue Therapeutics | 2.70M |
Revelation Biosciences | 2.65M |
NovaBay Pharmaceuticals | 2.62M |
Tivic Health Systems | 2.52M |
Aclarion | 2.51M |